| Name | Title | Contact Details |
|---|
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.
Post Printing is a West Bend, WI-based company in the Business Services sector.
Woodruff-Sawyer and Company is a San Francisco, CA-based company in the Business Services sector.
WARE continues to be a growing company. Our employees are our most valued asset. We owe our success to our loyal, dedicated hardworking and highly skilled workforce.
Custom home builders that design with style, character, and stellar craftsmanship. Legacy South homes set the scene for your most intimate moments.